Literature DB >> 33534204

Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era.

Giordano Madeddu1, Andrea De Vito1, Alessandro Cozzi-Lepri2, Antonella Cingolani3, Franco Maggiolo4, Carlo Federico Perno5, Roberta Gagliardini6, Giulia Marchetti7, Annalisa Saracino8, Antonella d'Arminio Monforte7, Andrea Antinori6, Enrico Girardi9.   

Abstract

OBJECTIVE: Zero risk of linked HIV transmission in serodiscordant couples when the HIV-infected partner had viral load less than 200 copies/ml ('U status') was found in observational studies. We aimed at estimating the proportion of time in which 'U status' was maintained and identifying factors associated with the risk of losing it.
DESIGN: Observational cohort study.
METHODS: We included participants in the ICONA cohort who had reached an established 'U status' (viral load ≤200 copies/ml for >6 months) as of December 2010. The outcome was the number of person-days of follow-up (PDFU) above a viral load greater than 200 copies/ml, relative to the total number of PDFU observed. A logistic regression model was used to identify factors independently associated with the risk of losing 'U status'.
RESULTS: Eight thousand, two hundred and forty-one persons living with HIV were included in the analysis who contributed 2 670 888 PDFU. Of these, 1648 (20%) were women, 768 (9%) were people who inject drugs (PWID), and 2066 (25%) were foreign-born. The median of viral load measurements was 9 (IQR: 4-15). Overall, only 3.1% of PDFU were observed when viral load was above 200 copies/ml. The proportion of PDFU with viral load more than 200 copies/ml was higher than average in women (5.3%), unemployed (5.4%), PWID (4.7%), and in people with more than three previous virologic failures (6.3%). These variables were significant predictors of losing 'U status' in the multivariable logistic regression.
CONCLUSION: Our results reinforce the validity of the U=U message in real-world setting. However, we identified subsets of our study population at higher risk of losing the 'U status' for whom additional efforts are needed.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33534204     DOI: 10.1097/QAD.0000000000002825

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  Investigating latent syphilis in HIV treatment-experienced Ethiopians and response to therapy.

Authors:  Selamawit Girma; Wondwossen Amogne
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

2.  Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort.

Authors:  Andrea De Vito; Annarita Botta; Marco Berruti; Valeria Castelli; Vincenzo Lai; Chiara Cassol; Alessandro Lanari; Giulia Stella; Adrian Shallvari; Antonia Bezenchek; Antonio Di Biagio
Journal:  J Pers Med       Date:  2022-01-31

3.  Treatment failure, death, and predictors among PLWHIV on second-line antiretroviral therapy in Dessie Comprehensive Specialized Hospital, northeast Ethiopia: A retrospective cohort study.

Authors:  Shambel Wedajo; Getu Degu; Amare Deribew; Fentie Ambaw
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

4.  HIV serostatus disclosure to sexual partner: a survey among women in Tehran, Iran.

Authors:  Zahra Pashaei; Fatemeh Oskouie; Maziar Moradi-Lakeh; Shayesteh Jahanfar; Shima Haghani
Journal:  Eur J Med Res       Date:  2022-04-08       Impact factor: 2.175

5.  Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort study.

Authors:  Anita Mesic; Tom Decroo; Htay Thet Mar; Bart K M Jacobs; Moe Pyae Thandar; Thin Thin Thwe; Aung Aung Kyaw; Mitchell Sangma; David Beversluis; Elkin Bermudez-Aza; Alexander Spina; Darli Po Po Aung; Erwan Piriou; Koert Ritmeijer; Josefien Van Olmen; Htun Nyunt Oo; Lutgarde Lynen
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

6.  How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population.

Authors:  Andrea De Vito; Agnese Colpani; Beatrice Zauli; Maria Chiara Meloni; Marco Fois; Vito Fiore; Giovanni Antonio Pintus; Vincenzo Gesualdo Nardi; Sergio Babudieri; Giordano Madeddu
Journal:  Healthcare (Basel)       Date:  2022-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.